95 related articles for article (PubMed ID: 22433466)
1. A designer hyper interleukin 11 (H11) is a biologically active cytokine.
Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A
BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466
[TBL] [Abstract][Full Text] [Related]
2. The length of the interleukin-11 receptor stalk determines its capacity for classic signaling.
Lokau J; Garbers C
J Biol Chem; 2018 Apr; 293(17):6398-6409. PubMed ID: 29523682
[TBL] [Abstract][Full Text] [Related]
3. Biophysical insight into protein-protein interactions in the Interleukin-11/Interleukin-11Rα/glycoprotein 130 signaling complex.
Mori C; Nagatoishi S; Matsunaga R; Kuroda D; Nakakido M; Tsumoto K
Biochem Biophys Res Commun; 2023 Nov; 682():174-179. PubMed ID: 37820452
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.
Sales KJ; Grant V; Cook IH; Maldonado-Pérez D; Anderson RA; Williams AR; Jabbour HN
Am J Pathol; 2010 Jan; 176(1):435-45. PubMed ID: 20008143
[TBL] [Abstract][Full Text] [Related]
5. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the craniosynostosis-associated interleukin-11 receptor variants p.T306_S308dup and p.E364_V368del.
Kespohl B; Hegele AL; Düsterhöft S; Bakker H; Buettner FFR; Hartig R; Lokau J; Garbers C
FEBS J; 2024 Apr; 291(8):1667-1683. PubMed ID: 37994264
[TBL] [Abstract][Full Text] [Related]
7. Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.
Stuhlmann-Laeisz C; Lang S; Chalaris A; Krzysztof P; Enge S; Eichler J; Klingmüller U; Samuel M; Ernst M; Rose-John S; Scheller J
Mol Biol Cell; 2006 Jul; 17(7):2986-95. PubMed ID: 16624864
[TBL] [Abstract][Full Text] [Related]
8. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway.
Wu X; Cao Y; Xiao H; Feng J; Lin J
J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency.
Gardner S; Jin Y; Fyfe PK; Voisin TB; Bellón JS; Pohler E; Piehler J; Moraga I; Bubeck D
Nat Commun; 2024 Mar; 15(1):2071. PubMed ID: 38453915
[TBL] [Abstract][Full Text] [Related]
10. Inborn errors of IL-6 family cytokine responses.
Chen YH; Spencer S; Laurence A; Thaventhiran JE; Uhlig HH
Curr Opin Immunol; 2021 Oct; 72():135-145. PubMed ID: 34044328
[TBL] [Abstract][Full Text] [Related]
11. Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.
Dmello RS; Palmieri M; Thilakasiri PS; Doughty L; Nero TL; Poh AR; To SQ; Lee EF; Douglas Fairlie W; Mielke L; Parker MW; Poon IKH; Batlle E; Ernst M; Chand AL
Cell Death Dis; 2024 Apr; 15(4):255. PubMed ID: 38600086
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of Interleukin-(IL)-11/IL-11R in Bone Metabolism and Homeostasis: From Cytokine to Osteokine.
Dong B; Zhu J; Chen X; Jiang H; Deng Y; Xu L; Wang Y; Li S
Aging Dis; 2023 Dec; 14(6):2113-2126. PubMed ID: 37199584
[TBL] [Abstract][Full Text] [Related]
13. Exploring the landscape of synthetic IL-6-type cytokines.
Scheller J; Ettich J; Wittich C; Pudewell S; Floss DM; Rafii P
FEBS J; 2024 May; 291(10):2030-2050. PubMed ID: 37467060
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic Cleavage Governs Interleukin-11 Trans-signaling.
Lokau J; Nitz R; Agthe M; Monhasery N; Aparicio-Siegmund S; Schumacher N; Wolf J; Möller-Hackbarth K; Waetzig GH; Grötzinger J; Müller-Newen G; Rose-John S; Scheller J; Garbers C
Cell Rep; 2016 Feb; 14(7):1761-1773. PubMed ID: 26876177
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion.
Stuart SF; Curpen P; Gomes AJ; Lan MC; Nie S; Williamson NA; Kannourakis G; Morokoff AP; Achuthan AA; Luwor RB
Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38248304
[TBL] [Abstract][Full Text] [Related]
16. Targeting IL-6 trans-signalling: past, present and future prospects.
Rose-John S; Jenkins BJ; Garbers C; Moll JM; Scheller J
Nat Rev Immunol; 2023 Oct; 23(10):666-681. PubMed ID: 37069261
[TBL] [Abstract][Full Text] [Related]
17. The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis.
Stuart SF; Bezawork-Geleta A; Areeb Z; Gomez J; Tsui V; Zulkifli A; Paradiso L; Jones J; Nguyen HPT; Putoczki TL; Licciardi PV; Kannourakis G; Morokoff AP; Achuthan AA; Luwor RB
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834778
[TBL] [Abstract][Full Text] [Related]
18. IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells.
Widjaja AA; Viswanathan S; Wei Ting JG; Tan J; Shekeran SG; Carling D; Lim WW; Cook SA
iScience; 2022 Aug; 25(8):104806. PubMed ID: 35992082
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts.
Widjaja AA; Viswanathan S; Jinrui D; Singh BK; Tan J; Wei Ting JG; Lamb D; Shekeran SG; George BL; Schafer S; Carling D; Adami E; Cook SA
Front Mol Biosci; 2021; 8():740650. PubMed ID: 34651016
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
